Adela Rodríguez (Adela Rodriguez)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Metastatic Colorectal Cancer

Transforming Growth Factor

Genome Wide Identification

Top Venues

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sara Lahoz, Adela Rodríguez, Laia Fernández, Teresa Gorría, Reinaldo Moreno, Francis Esposito, Helena Oliveres, Santiago Albiol, Tamara Saurí, David Pesantez, Gisela Riu, Miriam Cuatrecasas, Pedro Jares, Leire Pedrosa, Estela Pineda Losada, Antonio Postigo, Antoni Castells, Aleix Prat, Joan Maurel, Jordi Camps
Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53 -Mutated Metastatic Colorectal Cancer. Cancers 14 (23) (2022)
Sara Lahoz, Adela Rodríguez, Laia Fernández, Teresa Gorría, Reinaldo Moreno, Francis Esposito, Helena Oliveres, Santiago Albiol, Tamara Saurí, David Pesantez, Gisela Riu, Miriam Cuatrecasas, Pedro Jares, Leire Pedrosa, Estela Pineda Losada, Antonio Postigo, Antoni Castells, Aleix Prat, Joan Maurel, Jordi Camps
Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53 -Mutated Metastatic Colorectal Cancer. Cancers 14 (23) (2022)
Sara Lahoz, Adela Rodríguez, Laia Fernández, Teresa Gorría, Reinaldo Moreno, Francis Esposito, Helena Oliveres, Santiago Albiol, Tamara Saurí, David Pesantez, Gisela Riu, Miriam Cuatrecasas, Pedro Jares, Leire Pedrosa, Estela Pineda Losada, Antonio Postigo, Antoni Castells, Aleix Prat, Joan Maurel, Jordi Camps
Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53 -Mutated Metastatic Colorectal Cancer. Cancers 14 (23) (2022)
Adela Rodríguez, Francis Esposito, Helena Oliveres, Ferràn Torres, Joan Maurel
Are Quality of Randomized Clinical Trials and ESMO-Magnitude of Clinical Benefit Scale Two Sides of the Same Coin, to Grade Recommendations for Drug Approval? Journal of clinical medicine 10 (4) (2021)